► Click here to download the full text file (PDF).
In response to government initiatives and targets to reduce waiting times and move diagnostics closer to the patient, services offering improved patient driven point of care testing are escalating. This has subsequently led to increased demand for the ABX Pentra 60C+ where 5-part differential is required – eg oncology clinics and A&E - as laboratory quality results are provided in a POCT setting and importantly within 60 seconds.
This Case Study discusses how the ABX Pentra 60C+ hematology analyzer has significantly reduced waiting times in busy oncology clinics by eliminating delays in results delivery.
Sie haben Fragen oder Wünsche? Nutzen Sie dieses Formular, um mit unseren Spezialisten in Kontakt zu treten.